Cipher Pharmaceuticals Ltd. (CPHMF) Financials Nov 13, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Cipher Pharmaceuticals Ltd.
Fiscal year is January-December. All values CAD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 3.18M 5.39M 3.57M 8.46M 27.01M
Cost of Goods Sold (COGS) incl. D&A - 757,000 - - 1.25M
COGS excluding D&A - 0 - - 126,000
Depreciation & Amortization Expense 810,000 757,000 615,000 1.05M 1.12M
Depreciation - 53,000 37,000 20,000 16,000
Amortization of Intangibles 741,000 704,000 578,000 1.03M 1.11M
Gross Income - 4.63M - - 25.76M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 5.21M 4.52M 5.35M 5.02M 7.6M
Research & Development 956,000 743,000 2.21M 1.52M 1.39M
Other SG&A 4.25M 3.78M 3.15M 3.51M 6.21M
Other Operating Expense - 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 124,000 0 0 0 0
Non-Operating Interest Income - 66,000 89,000 155,000 253,000
Equity in Affiliates (Pretax) - 0 0 0 0
Interest Expense - 0 0 0 0
Gross Interest Expense - 0 0 0 0
Interest Capitalized - 0 0 0 0
Pretax Income (2.72M) 172,000 (2.31M) 2.54M 18.41M
Income Tax 0 0 0 0 (6.56M)
Income Tax - Current Domestic - 0 0 0 -
Income Tax - Current Foreign - 0 0 0 -
Income Tax - Deferred Domestic - 0 0 0 -
Income Tax - Deferred Foreign - 0 0 0 -
Income Tax Credits - 0 0 0 -
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income (2.72M) 172,000 (2.31M) 2.54M 24.97M
Minority Interest Expense 0 0 0 0 0
Net Income (2.72M) 172,000 (2.31M) 2.54M 24.97M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.72M) 172,000 (2.31M) 2.54M 24.97M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.72M) 172,000 (2.31M) 2.54M 24.97M
EPS (Basic) (0.11) 0.01 (0.10) 0.10 1.02
Basic Shares Outstanding 24.05M 24.07M 24.18M 24.38M 24.56M
EPS (Diluted) (0.11) 0.01 (0.10) 0.10 0.97
Diluted Shares Outstanding 24.05M 24.07M 24.18M 24.67M 25.68M
EBITDA (2.03M) 863,000 (1.79M) 3.43M 19.28M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Cipher Pharmaceuticals Ltd.
Fiscal year is January-December. All values CAD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 3.18M 5.39M 3.57M 8.46M 27.01M
Cost of Goods Sold (COGS) incl. D&A - 757,000 - - 1.25M
COGS excluding D&A - 0 - - 126,000
Depreciation & Amortization Expense 810,000 757,000 615,000 1.05M 1.12M
Depreciation - 53,000 37,000 20,000 16,000
Amortization of Intangibles 741,000 704,000 578,000 1.03M 1.11M
Gross Income - 4.63M - - 25.76M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 5.21M 4.52M 5.35M 5.02M 7.6M
Research & Development 956,000 743,000 2.21M 1.52M 1.39M
Other SG&A 4.25M 3.78M 3.15M 3.51M 6.21M
Other Operating Expense - 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 124,000 0 0 0 0
Non-Operating Interest Income - 66,000 89,000 155,000 253,000
Equity in Affiliates (Pretax) - 0 0 0 0
Interest Expense - 0 0 0 0
Gross Interest Expense - 0 0 0 0
Interest Capitalized - 0 0 0 0
Pretax Income (2.72M) 172,000 (2.31M) 2.54M 18.41M
Income Tax 0 0 0 0 (6.56M)
Income Tax - Current Domestic - 0 0 0 -
Income Tax - Current Foreign - 0 0 0 -
Income Tax - Deferred Domestic - 0 0 0 -
Income Tax - Deferred Foreign - 0 0 0 -
Income Tax Credits - 0 0 0 -
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income (2.72M) 172,000 (2.31M) 2.54M 24.97M
Minority Interest Expense 0 0 0 0 0
Net Income (2.72M) 172,000 (2.31M) 2.54M 24.97M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.72M) 172,000 (2.31M) 2.54M 24.97M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.72M) 172,000 (2.31M) 2.54M 24.97M
EPS (Basic) (0.11) 0.01 (0.10) 0.10 1.02
Basic Shares Outstanding 24.05M 24.07M 24.18M 24.38M 24.56M
EPS (Diluted) (0.11) 0.01 (0.10) 0.10 0.97
Diluted Shares Outstanding 24.05M 24.07M 24.18M 24.67M 25.68M
EBITDA (2.03M) 863,000 (1.79M) 3.43M 19.28M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
